Next Article in Journal
Dual Bioactivities of Essential Oil Extracted from the Leaves of Artemisia argyi as an Antimelanogenic versus Antioxidant Agent and Chemical Composition Analysis by GC/MS
Next Article in Special Issue
The Role of Vascular Endothelial Growth Factor A Polymorphisms in Breast Cancer
Previous Article in Journal
An Advanced Electron Spin Resonance (ESR) Spin-Trapping and LC/(ESR)/MS Technique for the Study of Lipid Peroxidation
Previous Article in Special Issue
Protein Profiling of Blood Samples from Patients with Hereditary Leiomyomatosis and Renal Cell Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model

San Martino-IST, Largo Rosanna Benzi 10, 16132 Genoa, Italy
Department of Experimental Medicine (DiMES), University of Genoa, 16132 Genoa, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(11), 14667-14678;
Received: 26 September 2012 / Revised: 22 October 2012 / Accepted: 5 November 2012 / Published: 12 November 2012
(This article belongs to the Special Issue Advances in Molecular Oncology (special issue))
Tumor progression is a key aspect in oncology. Not even the overexpression of a powerful oncogenic stimulus such as platelet derived growth factor-B (PDGF-B) is sufficient per se to confer full malignancy to cells. In previous studies we showed that neural progenitors overexpressing PDGF-B need to undergo progression to acquire the capability to give rise to secondary tumor following transplant. By comparing the expression profile of PDGF-expressing cells before and after progression, we found that progressed tumors consistently downregulate the expression of the antiproliferative gene Btg2. We therefore tested whether the downregulation of Btg2 is sufficient and necessary for glioma progression with loss and gain of function experiments. Our results show that downregulation of Btg2 is not sufficient but is necessary for tumor progression since the re-introduction of Btg2 in fully progressed tumors dramatically impairs their gliomagenic potential. These results suggest an important role of Btg2 in glioma progression. Accordingly with this view, the analysis of public datasets of human gliomas showed that reduced level of Btg2 expression correlates with a significantly worse prognosis. View Full-Text
Keywords: glioma progression; tumor suppressor; high grade oligodendroglioma glioma progression; tumor suppressor; high grade oligodendroglioma
Show Figures

MDPI and ACS Style

Appolloni, I.; Curreli, S.; Caviglia, S.; Barilari, M.; Gambini, E.; Pagano, A.; Malatesta, P. Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model. Int. J. Mol. Sci. 2012, 13, 14667-14678.

AMA Style

Appolloni I, Curreli S, Caviglia S, Barilari M, Gambini E, Pagano A, Malatesta P. Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model. International Journal of Molecular Sciences. 2012; 13(11):14667-14678.

Chicago/Turabian Style

Appolloni, Irene, Sebastiano Curreli, Sara Caviglia, Manuela Barilari, Eleonora Gambini, Aldo Pagano, and Paolo Malatesta. 2012. "Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model" International Journal of Molecular Sciences 13, no. 11: 14667-14678.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop